Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

A case of rhabdomyolysis in the presence of multiple risk factors and dextroamphetamine use.

Santoro JD, Black JM, Hamm LL.

Am J Med Sci. 2013 Jun;345(6):494-6. doi: 10.1097/MAJ.0b013e3182798040.

PMID:
23276898
[PubMed - indexed for MEDLINE]
2.

Rhabdomyolysis associated with the nutritional supplement Hydroxycut.

Dehoney S, Wellein M.

Am J Health Syst Pharm. 2009 Jan 15;66(2):142-8. doi: 10.2146/ajhp070640. Erratum in: Am J Health Syst Pharm. 2009 Feb 15;66(4):328. Dosage error in article text.

PMID:
19139478
[PubMed - indexed for MEDLINE]
3.

A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.

Weiss M, Hechtman L; Adult ADHD Research Group.

J Clin Psychiatry. 2006 Apr;67(4):611-9.

PMID:
16669726
[PubMed - indexed for MEDLINE]
4.

Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.

Nolan EE, Gadow KD, Sprafkin J.

Pediatrics. 1999 Apr;103(4 Pt 1):730-7.

PMID:
10103294
[PubMed - indexed for MEDLINE]
5.

Lisdexamfetamine in the treatment of attention-deficit/hyperactivity disorder in adults.

Rostain AL.

Curr Psychiatry Rep. 2009 Oct;11(5):341-2. No abstract available.

PMID:
19785973
[PubMed - indexed for MEDLINE]
6.

Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.

Taylor FB, Russo J.

J Child Adolesc Psychopharmacol. 2000 Winter;10(4):311-20.

PMID:
11191692
[PubMed - indexed for MEDLINE]
7.

Attention-deficit/hyperactivity disorder: the road traveled and the road ahead.

Jun A.

Am J Health Syst Pharm. 2009 Nov 15;66(22):2003. doi: 10.2146/ajhp090284. No abstract available.

PMID:
19890082
[PubMed - indexed for MEDLINE]
8.

Treatment of attention-deficit-hyperactivity disorder.

Elia J, Ambrosini PJ, Rapoport JL.

N Engl J Med. 1999 Mar 11;340(10):780-8. Review. No abstract available.

PMID:
10072414
[PubMed - indexed for MEDLINE]
9.

Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.

Lurie S, O'Quinn A.

J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):41-50. Review.

PMID:
7580171
[PubMed - indexed for MEDLINE]
10.

Managing stimulant medication for attention-deficit/hyperactivity disorder.

Wender EH.

Pediatr Rev. 2001 Jun;22(6):183-90. Review. No abstract available. Erratum in: Pediatr Rev 2001 Sep;22(9):292.

PMID:
11389305
[PubMed - indexed for MEDLINE]
11.

Methylphenidate and dextroamphetamine-induced peripheral vasculopathy.

Syed RH, Moore TL.

J Clin Rheumatol. 2008 Feb;14(1):30-3. doi: 10.1097/RHU.0b013e3181639aaa.

PMID:
18431096
[PubMed - indexed for MEDLINE]
12.

An update on attention deficit disorder.

[No authors listed]

Harv Ment Health Lett. 2004 May;20(11):4-7. No abstract available.

PMID:
15153391
[PubMed - indexed for MEDLINE]
13.

Hydroxycut weight loss dietary supplements: a contributing factor in the development of exertional rhabdomyolysis in three U.S. Army soldiers.

Carol ML.

Mil Med. 2013 Sep;178(9):e1039-42. doi: 10.7205/MILMED-D-13-00133.

PMID:
24005555
[PubMed - indexed for MEDLINE]
14.

Attention deficit hyperactivity disorder in children.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2002 Jun;(7):262-71. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):280-90.

PMID:
12230649
[PubMed - indexed for MEDLINE]
15.

No pain, no gain--exercise-induced rhabdomyolysis associated with the performance enhancer herbal supplement ephedra.

Stahl CE, Borlongan CV, Szerlip M, Szerlip H.

Med Sci Monit. 2006 Sep;12(9):CS81-4.

PMID:
16940935
[PubMed - indexed for MEDLINE]
16.

Attention deficit hyperactivity disorder in children.

Ramchandani P, Joughin C, Zwi M.

Clin Evid. 2002 Dec;(8):280-90. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):318-27.

PMID:
12603883
[PubMed - indexed for MEDLINE]
17.

A case of occult compartment syndrome and nonresolving rhabdomyolysis.

Minnema BJ, Neligan PC, Quraishi NA, Fehlings MG, Prakash S.

J Gen Intern Med. 2008 Jun;23(6):871-4. doi: 10.1007/s11606-008-0569-1. Epub 2008 Mar 19. Review.

PMID:
18350340
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder.

Paterson R, Douglas C, Hallmayer J, Hagan M, Krupenia Z.

Aust N Z J Psychiatry. 1999 Aug;33(4):494-502.

PMID:
10483843
[PubMed - indexed for MEDLINE]
19.

Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.

Williams RJ, Goodale LA, Shay-Fiddler MA, Gloster SP, Chang SY.

Am J Addict. 2004 Jul-Sep;13(4):381-9.

PMID:
15370936
[PubMed - indexed for MEDLINE]
20.

[Substitution of dexamethasone for dexamphetamine due to their written and spoken similarity].

Hoppenbrouwers CJ, Mooren GC, van den Heuvel JJ, Op de Coul ME, van Trotsenburg PA.

Ned Tijdschr Geneeskd. 2010;154:A1662. Dutch.

PMID:
20858310
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk